{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:47:16Z","timestamp":1772171236166,"version":"3.50.1"},"reference-count":21,"publisher":"Baishideng Publishing Group Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastroenterol"],"abstract":"<jats:p>With the introduction of Janus kinase inhibitors like tofacitinib, the treatment landscape for ulcerative colitis (UC) is changing quickly. Response heterogeneity is still a significant clinical challenge in spite of its quick onset and oral convenience. Extending tofacitinib induction beyond the standard eight weeks can produce significant benefits in a subset of patients without sacrificing safety, according to evidence from pivotal trials and real-world studies. We review recent real-world evidence, highlight lessons learnt from extended induction therapy, and present a practical framework to help guide tailored treatment decisions in this editorial. After 16 weeks of prolonged induction, more than half of patients with moderate-to-severe UC experienced remission, with durable persistence and favorable safety, according to a multicenter 52-week real-world study published in this issue of the World Journal of Gastroenterology . Crucially, outcomes and maintenance dosing were impacted by modifiable factors like smoking and biologic exposure. Mechanistic findings support a response-guided rather than fixed-duration induction paradigm by indicating that immune kinetics, mucosal healing rates, and previous biologic exposure may account for delayed responses. An effective, patient-centered strategy that could maximize tofacitinib\u2019s therapeutic potential and assist in guiding refractory UC patients towards long-term remission is extended induction.<\/jats:p>","DOI":"10.3748\/wjg.v32.i9.115785","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:28:39Z","timestamp":1772162919000},"source":"Crossref","is-referenced-by-count":0,"title":["Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis"],"prefix":"10.3748","volume":"32","author":[{"given":"Yasser","family":"Fouad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S","family":"Aboelela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i42.111282"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00311.2015"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-020-00789-9"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.04.016"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.04.014"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00984-3"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.10.038"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab075.023"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112168"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2018.0276"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2024-001347"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab011"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001608"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201710001-00714"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa145"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0772-7"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.51"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01069-8"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241272001"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v32\/i9\/115785.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v32\/i9\/115785.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:31:14Z","timestamp":1772163074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v32\/i9\/115785.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":21,"journal-issue":{"issue":"9"},"alternative-id":["115785"],"URL":"https:\/\/doi.org\/10.3748\/wjg.v32.i9.115785","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,7]]}}}